AI assistant
TI Fluid Systems PLC — Director's Dealing 2018
Oct 2, 2018
5340_dirs_2018-10-02_84dd32e9-16e3-44fc-9382-0f9253bf0a5f.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 7255C
TI Fluid Systems PLC
02 October 2018
2 October 2018
TI Fluid Systems plc
Notification of transactions of Directors/ Persons Discharging Managerial Responsibilities ("PDMRs")
The following notifications, made pursuant to Article 19(3) of the EU Market Abuse Regulation.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Neil Carson
2
Reason for the notification
a)
Position/status
Deputy Chairman and Senior Independent Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
TI Fluid Systems plc
b)
LEI
5493001T9RXVD6OAWY46
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of TI Fluid Systems plc of £0.01 each
GB00BYQB9V88
b)
Nature of the transaction
Purchase of shares
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £2.4975 per share | 676 Ordinary Shares |
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
1 October 2018
f)
Place of the transaction
XLON
Enquiries:
TI Fluid Systems plc
Matthew Paroly
Company Secretary +44 (0)1865 871855
FTI Consulting +44 (0)20 3727 1340
Richard Mountain
Nick Hasell
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHBXBDGXDGBGID